Prostate Cancer:A Public Health Problem
Main Article Content
Abstract
Prostate cancer is an affectation acquired in old age, men who develop it may have genetic factors, other predisposing diseases such as benign prostatic hyperplasia and bad habits such as alcoholism and smoking that may be the cause of developing the affectation. The identification of risk factors as well as their early treatment can significantly reduce morbidity and mortality
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 9th Ed. Philadelphia. Elsevier; 2015
II. Harrison: Principles of Internal Medicine, 20th Edition. McGraw-Hill Interamericana de España 1998. Farreras-Rozman: Internal Medicine, 20th Edition.
III. H. Roffo A. Guidelines in oncology: diagnosis, treatment, and follow-up of cancer. 1st ed. Buenos Aires, Argentina: Dr. Bertha Roth; 2010.
IV. Trujillo Cáceres, S., Torres Sánchez, L., Burguete García, A., Orbe Orihuela, Y., Vázquez Salas, R., Álvarez Topete, E., & Gómez, R. (2019). Contribution of MSMB promoter region gene polymorphism to early-onset prostate cancer risk in Mexican males. Retrieved from http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=26592&path[]=82711
V. Won, H., Moreira, D., Gao, C., Duttagupta, P., Zhao, X., & Yuan, Y. et al. (2019). TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs. Journal of leukocyte biology, 102(2), 423-436. doi:10.1189/jlb.3MA1016-451RR Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505743/
VI. Mohar-Betancourt, A., Reynoso-Noverón, N., Armas-Texta, D., Gutiérrez-Delgado, C., & Torres-Domínguez, J. A. (2017). Cancer Trends in Mexico: Essential Data for the Creation and Follow-Up of Public Policies. Journal of global oncology, 3(6), 740-748. doi:10.1200/JGO.2016.007476.
VII. Patel, N., Bloom, J., Hillelsohn, J., Fullerton, S., Allman, D., & Matthews, G. et al. (2018). Prostate Cancer Screening Trends After United States Preventative Services Task Force Guidelines in an Underserved Population | Health Equity. Retrieved from https://www.liebertpub.com/doi/10.1089/heq.2018.0004
VIII. Howard I. Scher, Kirk Solo, Jason Valant, Mary B. Todd, Maneesha Mehra (October 13, 2015). Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model. March 4, 2019 , from Plos one. Website: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0139440&type=printable
IX. Verónica Tableros Hidalgo, Juan Manuel Sánchez Soto, Cristina Juárez Landín, Magally Martínez Reyes, Anabelem Soberanes Martín (May 2018). Mathematical Model of the Incidence Prostate Cancer in Mexico. March 1, 2019. from International Journal of Latest Engineering and Management Research (IJLEMR) Website: http://www.ijlemr.com/papers/volume3-issue3/1-IJLEMR-33071.pdf.
X. Hoffman, R., Meisner, A., Arap, W., Barry, M., Shah, S., Zeliadt, S., & Wiggins, C. (2015). Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012. Retrieved from http://cebp.aacrjournals.org/content/25/2/259
XI. Wilt, T., Jones, K., Barry, M., Andriole, G., Culkin, D., Wheeler, T., & Aronson, W. (2017). Follow-up of Prostatectomy versus Observation for Early Prostate Cancer | NEJM. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa1615869
XII. J. Deloumeaux, B. Bhakkan,R. Eyraud,F. Braud3,N. Manip M'Ebobisse, P. Blanchet, L. Brureau. Prostate cancer clinical presentation, incidence, mortality and survival in Guadeloupe over the period 2008-2013 from a population-based cancer registry. Cancer Causes Control. 2017;28:1265-1273.Carolyn K. Kan MPH, Muhammad M. Qureshi, (2017).
XIII. Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by rick category in an academic safety net hospital, https://www.ncbi.nlm.nih.gov/pubmed/29904743
XIV. DOI: 10.1200/JCO.2017.75.3657 Journal of Clinical Oncology 36, no. 11 (April 10 2018) 1080-1087.
XV. Mohler JL, Armstrong AJ, Bahnson RR, Boston B, Busby JE, D'Amico AV, et al. NCCN clinical guidelines in oncology-prostate cancer. Version I.2015. National Comprehensive Cancer Network Website. Available: http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.